BD Makes Pharma Debut With Generic Prefilled Syringe
This article was originally published in The Gray Sheet
Executive Summary
BD gained FDA approval for the first in a line of prefilled generic injectable drugs that will be marketed by its new subsidiary, BD Rx.
You may also be interested in...
News In Brief
Bypass surgery beats coronary intervention in multivessel disease patients. Medical device excise tax repeal efforts criticized in NEJM commentary. More news.
FDA Glass Syringe Guidance Aims To Solve Connectivity Problems
Following a series of adverse events, an FDA draft guidance on glass syringes recommends supplemental tests to ensure device safety and effectiveness.
Regulatory News In Brief
CDRH pursuing workplace fixes